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Abstract
Introduction
The prevalence of obesity keeps increasing worldwide, 
bring along the metabolic diseases as its consequences. 
Researchers keep their attention to the low‐grade, chronic 
inflammation, suspected as the underlying mechanisms of 
obesity and its co‐morbidities, including type 2 diabetes 
mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), 
steatohepatitis, asthma, cancer, cardiovascular diseases 
(CVD) and neurodegenerative diseases.(1)
 Adipocytes was previously known as a storage of 
excessive energy we consumed, with the help of insulin, 
change nutrients into triglycerides or glycogen in adipocytes 
and myocytes.(2) Adipocytes are able to sense energy 
storage in a cell‐autonomous manner, and secretes some 
hormones to manage food intake signals at the sympathetic 
nervous system.(3-5) This action will release adrenaline 
and noradrenaline from nerve terminals in adipose tissue 
(AT), and induce lipolysis and thermogenic processes via 
β‐adrenergic receptors activating on adipocytes.(4-6) The 
closed‐loop brain–adipocyte axis presents the adipocyte 
crosstalk with other tissues to control energy storage 
and mobilization.(7) Evidently, the role of adipocytes in 
managing systemic energy metabolism is not as simple 
as that, many factors and mechanisms are involved, 
for instance some protein expressed by the adipocytes 
including adiponectin and fibroblast growth factor (FGF)-
21, as well as cytokines and inflammatory proteins (8), and 
the thermogenesis process performed by brown adipocytes.
 Brown Adipose Tissue (BAT), are so-called due to its 
brownish color, results from a high mitochondrial content 
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BACKGROUND: Obesity has been decades become a highly interest study, accompanied by the realization that adipose tissue (AT) plays a major 
role in the regulation of metabolic function.
CONTENT: In past few years, adipocytes classification, 
development, and differentiation has been significant 
changes. The white adipose tissue (WAT) can transform to 
a phenotype like brown adipose (BAT) type and function. 
Exercise  and  cold  induction  were  the  most  common 
factor for fat browning; however batokines such as fibroblast 
growth factor (FGF)-21, interleukin (IL)-6, Slit homolog 2 
protein (SLIT2)-C, and Meteorin-like protein (METRNL) 
perform a beneficial browning action by increasing 
peroxisome proliferator-activated receptor gamma co-
activator (PGC)-1α protein levels, a key factor to stimulate 
mitochondrial biogenesis and uncoupling Protein 1 (UCP1) 
transcription, thus change the WAT phenotype into beige.
SUMMARY:  AT recently known as a complex organ, not 
only bearing a storage function but as well as the master 
regulator of energy balance and nutritional homeostasis; 
brown and beige fat express constitutively high levels 
of thermogenic genes and raise our expectation on new 
strategies for fighting obesity and metabolic disorders.   
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Adipose Tissue Dysfunction in Obesity
AT defined to be dysfunction when it can no longer 
maintain the systemic metabolic homeostasis. The 
dysfunction pathogenesis mechanisms grouped into three 
main contributors: unresolved inflammation, inappropriate 
extracellular matrix (ECM) remodeling and insufficient 
angiogenic potential. Those three mechanisms interact in 
a linier model. When nutrient intake is excess, and stored 
in the adipocytes, the cells will expand and reach its limit, 
thus the diffusional limit of oxygen touch its limit. A mild 
Figure 1. The complex contributions of angiogenesis, inflammation, and fibrosis in healthy and unhealthy adipose tissue expansion. 
VEGF: vascular endothelial growth factor; HIF: hypoxia-inducible factors; ECM: extracellular matrix.(16) (Adopted with permission from 
American Society for Clinical Investigation).
and multilocular lipid droplets to perform its thermogenesis 
role. BAT is abundant in rodents and infant humans, the 
amounts reduced as a human grows adult but not diminished.
(9-11) Recent findings in rodents and human introduced the 
identification of beige adipocytes within subcutaneous white 
adipose depots, add more complexity to the thermogenic 
program.(3,12) Beige adipocytes differentiation was 
affected by various afferent and hormonal signals, involving 
the innate immune system in response to energy status.
(13,14) This lead to an interesting targets to resolve the 
problem of obesity and its co-morbidities.(15)
hypoxia will occur, induce stress signal to start angiogenesis 
and remodeling of the ECM to facilitate further expansion 
of AT (Figure 1). Until here, this process still regarded as a 
“healthy AT expansion”. However, a chronic overnutrition 
could lead in an inadequate angiogenic due to persistent 
hypoxia, and lead into inflammation, fibrosis, cellular 
senescence, and necrotic adipocyte death. The unhealthy 
AT expansion in the end will lead to chronic metabolic 
disturbances. Therefore, we need to understand the 
coordination of these triad as the resident of AT, including 
adipocytes, immune cells, endothelial cells, and fibroblasts, 
some examples are shown in Figure 1.(16)
 The precise triggers of obesity‐associated inflammation 
were not entirely understood. However, several potential 
mechanisms theories were developed, involving the gut‐
derived substance, and dietary component or metabolite. 
In our current understanding, the rapid expansion of 
AT in obesity will release intrinsic survival signals such 
as adipocyte death, hypoxia and mechano-transduction 
arising from interactions between the cell and the ECM, 
which might trigger an inflammatory response.(15) The 
signals expressed by dying adipocytes wish to solve their 
persistent hypoxia, but apparently invite immune cells and 
also recruit macrophages from blood monocytes to AT. The 
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M1 macrophages proliferate in crown‐like structures as 
seen in histology containing F4/80‐positive immune cells, 
and move throughout AT, amplify the inflammatory signals 
around AT, and invites more macrophages to join. This 
mechanism considered as the major driver of inflammation 
in AT dysfunction.(17-19) Stressed adipocytes express 
signals from damage‐associated molecular patterns that 
sensed by the nucleotide oligomerization domain (NOD)‐
like receptor (NLR) family of pattern recognition receptors 
(PRRs).(20) Activated NLR mobilize leukocytes to limit 
tissue damage.(21,22) NLRs also activates the NOD-like 
receptor protein 3 (NLRP3) inflammasome (also known as 
cryopyrin) in macrophages and promote the expression of 
interleukin (IL)‐1β and IL‐18 via caspase 1.(23) However, 
adipocytes also secrete pro-inflammatory mediators 
(cytokines, chemokines, and adipokines) and in larger 
amounts compared with immune cells.(24)
 Inadequate oxygen supply in the development of 
obesity (25,26) activates the transcription factor hypoxia-
inducible factor (HIF)-1α which induces cell death and 
further release of pro-inflammatory cytokines (27) and “self” 
antigens that stimulate class switch and the production of 
IgG pathogenic antibodies (28). The phenomenon describes 
a crosstalk between adipocytes and the immune cells which 
establish a chronic inflammation in obese AT, and possibly 
lead to insulin resistance (IR). Most macrophage in AT are 
M1 type or the classically activated macrophage. Hypoxia, 
via HIF-1α, potentiates glycolysis. Glycolysis activates M1 
inflammatory function, and induces glucose transporter 
expression and glucose intakes and utilizations in AT.(29,30) 
The inflammasome NLRP3 in M1 macrophages activates 
caspase 1 and the secretion of IL-1β (31), which is toxic 
to pancreatic β-cells and induces IR (32), as some studies 
reported increased inflammasome activity in monocyte-
derived macrophages (33).  On the contrary, M2 macrophages 
or alternative activated macrophages is associated to anti-
inflammatory properties. Hence, a reduce in a reduced ratio 
of pro-inflammatory M1-like adipose tissue macrophages 
(ATMs) to anti-inflammatory M2-like ATMs ratio indicate 
a phenotypic switch of AT macrophages which correlated to 
a pathophysiologic in AT health function.(25)
 Another potential mechanism for inflammation in 
adipocyte is mechanical stress. In response to obesity, 
adipocyte needs to differentiate and expand, involving 
an interaction with their basement membrane and ECM. 
Cell shape is able to utilize relays that depend on the actin 
cytoskeleton to regulate gene expression in numerous cell 
systems.(33) In addition to adipocytes, AT consist of a dense 
network of ECM proteins, particularly collagen 1.(34) 
Excess triglycerides storage in adipocytes in the ECM‐
fixed environment could lead mechanical stress. Indeed, 
inactivation of genes involved in collagens formation or 
degradation, particularly matrix metallopeptidase (MMP)-
14, will affect adipocyte function, lipid synthesis and storage, 
and overall energy metabolism.(35) Some significant 
contributor to inflammation related to aging process are cell 
senescence, the acquisition of the senescence-associated 
secretory phenotype (SASP) by fibroblasts (36) and 
endothelial (37) and immune cells (38) Cellular senescence 
is defined as irreversible cell cycle arrest driven by a variety 
of mechanisms, means that the cell ages and permanently 
stops dividing but does not die.  Activated senescence 
and energy-sensing signals cause dysregulated function of 
terminally differentiated B, T, and NK cells. 
 Bacteroidetes, known as beneficial bacteria that keeps 
you lean, versus Firmicutes, nicknamed as the negative 
bacteria, known to have an altered composition in obese 
and T2DM subjects either in human or animal.(39,40) T-bet 
regulates mucosal T cell activation.(41) Gut microflora 
composition will be altered if T-bet is deficient, and lead 
to inflammation and metabolic processes that regulate 
T2DM. Fat-associated lymphoid clusters (FALCs), a new 
lymphoid tissue recently identified in the mesenteric AT 
of mice and humans, known to be rapidly induced after 
inflammatory stimuli in AT, and  support B cell proliferation 
and differentiation regulating antibody production.(42,43) 
Chronic low-grade (sterile) inflammation, also known as 
metaflammation (metabolic inflammation) has become 
one characteristic in obesity, which leads the transition of 
obese metabolism from normal to IR (44), with metabolic 
hallmarks as high levels of lipids, free fatty acids (FFAs), 
glucose, and reactive oxygen species (ROS). Some initiators 
of obesity-associated inflammation in adipocytes is shown 
in Figure 2.
 Evidences showed association between inflammation 
and IR. Obese individuals with IR clearly exhibit a high degree 
of AT inflammation, compare to the obese with sensitive 
insulin.(45,46) Some molecular signaling pathways link 
the inflammation and metabolism. For instances, knocking 
out key pathways for inflammatory signaling in obese mice, 
including components of the nuclear factor kappa B (NF‐
κB) (46) and c‐Jun N‐terminal kinase (JNK) (47) pathways, 
as well as other molecules such as scaffolding proteins and 
cytokines, will block the link between obesity into IR  either 
directly or indirectly.(23,48,49)
 The nutrient storage in adipocyte is autoregulated by 
anabolic (insulin) and catabolic (leptin or catecholamine) 
signals. Resistance or failed response of adipocyte to 
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Figure 2. Initiators of obesity-associated inflammation in adipocytes. FFA: free fatty acid; TLR: toll-like receptor; ECM: extracellular 
matrix; NLR: nucleotide oligomerization domain‐like receptor; NLRP3: NLR protein 3; NF-kB: nuclear factor kappa B; 
DAMP: danger-associated molecular pattern.(15) (Adopted with permission from Springer Nature).
catabolic signals stimulate the excess preservation of energy, 
associated with obesity.(51-53) Fortunately, resistance to 
any of these signals is metabolically flexible.(51,54) Recent 
investigations moreover showed the relationship between 
inflammation and immune activation to long-term metabolic 
disease outcome lead a more comprehensive view for the 
effective therapeutic intervention.(27) Figure 3 shows the 
roles of ATM on obesity and its consequences in insulin 
resistance, metabolic syndrome and cardiometabolic risk.
Advances in The Understanding of Adipose Tissue Biology
The role of AT was not thought to be linked to metabolism in 
any possible way. Until the late 1940s, AT was characterized 
as a form of connective tissue that contains lipid droplets. 
The understanding progressively improved to be the 
storage organ after feeding and the “warehouse” of energy 
at fasting by releasing FFAs. The discovery of adipose-
derived serum factors like adipsin, tumor necrosis factor 
(TNF)-a, and leptin, began in the late 1980s to mid 1990s, 
lead a new thought of AT as an endocrine organ and have 
center role in homeostasis. Until currently, studies on the 
AT developmental, functional, and pathophysiological have 
expanded markedly.
 AT has a very unique feature, which is the capability 
to expand its dimension, either by increasing the single 
cell size (hypertrophy), or by recruiting new adipocytes 
from the resident pool of progenitors (hyperplasia). AT is 
the only non-neoplastic tissue having this capacity in this 
degree. Hypertrophy is the first mechanism occurred to 
compensate the overnutrition. Once the cell reached its 
critical threshold (~0.7–0.8 µg/cell), signals will be sent to 
induce proliferation and/or differentiation of preadipocytes 
into new adipocytes. Once adipocytes were attained, they 
were hard to eliminate. Only ~8% of human subcutaneous 
total number of adipocytes turn over each year. Even in 
significant weight loss, adipocyte volume will be reduced, 
but not the overall number.(55-57) Adipocytes may die via 
necrosis or apoptosis, we know that macrophages is the star 
player in this process, but how the process contributes is not 
clear.(17)
 Traditionally, positive energy balance equation 
become the benchmark that determine the adipogenesis, 
either due to overnutrition or reduced of energy expenditure 
and result in excess calories. Supposedly, we could align 
the same theory for any molecular effectors that induced 
positive energy balance by increased food intake or reduced 
energy expenditure.  New  adipocytes  formation  could  be 
considered as an adaptive way to handling the increased 
calories safely. AT capability to change its size requires a 
 89
Current Progress in Adipose Tissue Biology (Meiliana A, et al.)Indones  Biomed J. 2020; 12(2): 85-101DOI: 10.18585/inabj.v12i2.1171
Figure 3. Adipose tissue macrophages on obesity and its consequences in insulin resistance, metabolic syndrome and cardiometabolic 
risks and diseases.(51) (Adopted with permission from PIT PERKENI). 
unique capacity to remodel. Current evidences showed 
that dysfunction in AT remodeling become the hallmark 
events associating obesity with metabolic diseases.(58) AT 
remodeling concepts play the role in AT depots response to 
nutrient excess or deficiency.(59-62) Remodeling can be 
simply described as the changes in the cellular composition 
of the AT stromal cell network, in order to expand or 
contract AT.(61,62) The process of remodeling occurred by 
deposition and breakdown of the non-cellular components’ 
structures of AT, such as ECM. Besides nutrition, 
remodeling could also be induced by both physiological/
adaptive settings (e.g., embryonic development, puberty, 
pregnancy, and weight loss) or pathologic settings (e.g., 
obesity or lipodystrophy).(60)
 Adipocytes hypertrophy and hyperplasia cannot be 
separated from the event of hypoxia, almost parallels to 
tumor biology theory, where the tissue needs to expand 
rapidly and demands to outgrow tissue’s blood supply. 
In the effort of vascularization during AT expansion, 
hypoxia may develop.(63) Several proposed mechanism 
involving the actions of HIF-1a, suppression of b-oxidation 
via transcriptional repression of Sirtuin (SIRT)1, and 
deacetylation and activation of peroxisome proliferator-
activated receptor gamma (PPAR-g) coactivator 1 alpha 
(PGC-1a) (64), thus downregulating adiponectin and 
enhanced fibrosis and inflammation (65).
 Another study presented FGF1 as a critical mediator of 
adipose remodeling. The adipose morphology in the FGF1-/- 
mice were dramatically altered upon chronic overfeeding or 
fasting, accompanied by IR and dysglycemia.(1) A subgroup 
of obese subjects called themselves as the metabolically 
healthy obese (MHO). Marked by Col6a1-deficient and 
others with similar features they tend to have reduced 
visceral adiposity, increased adiponectin levels, reduced 
fibrosis and inflammation, and improved glucose and lipid 
homeostasis relative to other equally obese subjects.(66) 
MHO subject tends to have smaller adipocytes (67), suggest 
that in adipogenesis, numerous and smaller adipocytes have 
a better glucose uptake feature and a healthy adipokine 
profile, result in a healthier metabolic obese.
 Adipocytes develop from preadipocytes, which was 
derived from precursor cells with various disconcert name 
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in different literatures.(68) The most common name is 
stromal-vascular fraction (SVF). It could be separated from 
mature adipocytes by collagenase digestion and low-speed 
centrifugation. When cultured ex vivo, SVF separated into 
blood cells, endothelial cells, and other nonfibroblastic cells 
which  do  not  attach  to  the  dish,  and  the  remains 
which could almost completely differentiated, by addition 
of hormonal cocktail that typically includes insulin, a 
glucocorticoid, a phosphodiesterase inhibitor, and often a 
PPAR-g agonist.(69)
 The origin root of adipocyte is ectodermal.(70) In the 
cephalic region, neurectoderm arises into mesenchyme, 
which is primarily of mesodermal origin, and later develop 
into adipocyte. The fat pad consists of brown fat and white 
fat, suspected to share a common precursor but with different 
developmental pattern. However, later findings shown that 
classical brown fat derive from the same or very similar 
precursors with muscle cells, after the identification of the 
transcriptional cofactor PRD1-BF-1-RIZ1 homologous 
domain-containing protein-16 (PRDM16) as a dominant 
regulator of the brown fat program.(71) Altricial mammals 
such as mice and rats, which have a short gestation period 
and are born with an immature hypothalamic-pituitary-
adrenal (HPA) axis keep their body warm after born 
by huddling in the nest and not by using non-shivering 
thermogenesis, mainly through metabolism in brown fat. 
Beige adipocytes have the morphological appearance of a 
transition  form  between  white  and  brown  fat.  However, 
it was not derived from the same Pax7+Myf5+ precursor cells 
which give rise to classic interscapular BAT (72), shown 
that both were distinct cell types. A major theory proposed 
these  cells  arise  from  transdifferentiation  of  existing 
mature white adipocytes, coherent with an observation that 
cold  exposure  or  treatment  with  a  b3  agonist  does  not 
induce cellular proliferation in the newly browned fat pad.
(73,74)
 Both adipocytes and skeletal muscle derive from 
mesenchymal cells. They are intertwined in several 
interesting ways, share overlapping gene expression 
patterns,  and  skeletal  muscle  and  brown  fat  shared 
lineage  through  a  Myf5+  precursor.(75,76)  Fibro-
adipogenic precursor (FAP) found in skeletal muscle can 
differentiate into white adipocytes under certain conditions, 
including muscular dystrophy, obesity, and age-related 
sarcopenia.(77) 
 Lypolisis is a metabolic process which hydrolyze 
triglycerides into fatty acids (FA) and glycerols, thus the FA 
could be utilized either locally or by other organs. Lipolysis 
is induced by at least three major enzymes and associated 
cofactors, b-adrenergic signaling in the adipocyte, and 
other inducers (such as TNF-a).(78) The primary cleavage 
performed by adipose triglyceride lipase (ATGL), cut 
triacylglycerol to diacylglycerols. The enzyme will 
infer when the second enzyme in the pathway, hormone-
sensitive lipase (HSL) ablated. HSL cut diacylglycerols 
into monoglyceride, and will be finalized by monoglyceride 
lipase (MGL) generating glycerol and FFAs. So, these three 
enzymes account for >90% of the lipolytic activity in the 
adipocyte.(79) Insulin is the major physiological suppressor 
of lipolysis, but this process becomes impaired in obesity 
or IR condition. Insulin block lipolysis in many pathways. 
First, it activates phosphodiesterase 3b (PDE3b) via Akt-
mediated phosphorylationm it will reduce intracellular 
cyclic adenosine monophosphate (cAMP) levels and block 
protein kinase A (PKA) activation.(80,81) Another non-
canonical pathway block PKA selectively on Perilipin 
(Plin)1 through a phosphoinositide 3-kinases (PI3K)-
mediated, Akt-independent pathway.(82) 
 Recently, lipid droplet was known as a highly dynamic 
organelle with extraordinary conservation of its protein 
composition. More than 200 proteins were identified in 
adipocytes, including perilipin, the cell death-inducing 
DFF45-like effector (CIDE) family and various scaffolding 
proteins such as cavins and caveolins, associated with insulin 
sensitivity, and global energy homeostasis.(83) The protein 
known as adipokines, and they regulate energy storage and 
dissipation, which how ATs have a central role in energy 
homeostasis. Novel adipokines from white, brown and 
beige adipocytes keep popping up until recently, emphasize 
the AT role as endocrine organ.  Identifying the specific 
receptors for each adipokine will give critical insight about 
energy homeostasis signaling pathways (Figure 4).(84)
 Batokines is a specific name for adipokines secreted 
from BAT, and beige adipocytes, or so-called as thermogenic 
adipocytes, including FGF-21, neuregulin 4 (NRG4), 
vascular endothelial growth factor A (VEGFA) and bone 
morphogenetic protein 8B (BMP-8B).(85,86)
Brown And Beige Fat: Development, Function And Therapeutic Potential
All three types of AT, white, brown, and brown-in-white 
or beige fat communicate extensively with other organs in 
the body to maintain energy homeostasis, including skin, 
liver, pancreas, muscle, and brain.(87) AT is dynamic. It 
ranges from 4 to >4% of total body mass in adult humans. 
White fat as energy storage, while BAT and beige fat as 
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Figure 4. The regulation of 
systemic glucose homeostasis 
and insulin sensitivity through 
adipokines. PKA: protein 
kinase A; SLIT2: Slit homolog 
2 protein; PM20D1: peptidase 
M20 domain containing 1; IL: 
interlukin; PCSK1: Proprotein 
Convertase Subtilisin/Kexin 
Type 1;  cAPM: cyclic 
adenosine monophosphate.(84) 
(Adopted with permission from 
Springer Nature).
the whole-body energy homeostasis through non-shivering 
thermogenesis.(88) Thus, which different types of ATs will 
develop and function, and how is the mechanisms?(87)
 Adipocytes, skeletal muscle cells, chondrocytes, and 
bone cells derived from mesenchymal progenitor cells, 
initiated by progressive fate restrictions to become each 
type of cell and followed by differentiation to acquire the 
morphological and functional characteristics of mature 
cell. BAT originate from the same precursor cells that also 
give rise to skeletal muscle cells and a subpopulation of 
white adipocytes (72,89,90), in the embryonic mesoderm, 
during embryonic development before other fat depots, it 
was assumed the population of adipocytes are uniform. The 
precursors transiently express Myf5 and Pax7, the selective 
markers for skeletal myogenic cells in the mesoderm. 
BAT in rodents found majority in the interscapular region 
(interscapular, axillary and cervical pads), inlayed in and 
around deep back muscles, while in human infant BAT 
found in interscapular which regresses and is absent in 
adults.(9,89) Consistent with the precursors suspected, BAT 
also express many muscle-specific genes, and the highly 
related mitochondrial proteomes between BAT and muscle.
(76,91) Some genes play roles in BAT vs muscle cell fate, 
including PRDM16, CCAAT-enhancer-binding proteins or 
(C/EBP)-b, euchromatic histone-lysine N-methyltransferase 
1 (EHMT1), Ewing sarcoma gene (EWS), and Zfp516 
(72,92,93), especially EHMT1, an important coregulator of 
PRDM16, as well as EWS, is required for BAT development, 
and its deletion causes the ectopic expression of muscle 
genes in BAT (93).  While PRDM16, not required for BAT 
development in mice, but can potently suppress muscle gene 
expression, suggested that its absence will induce some 
compensate mechanisms.(94) Zfp516 which can activate its 
transcriptional activity when interact with PRDM16. Brown 
fat differentiation could me induced by placenta-specific 8 
(PLAC8) which is an upstream activator of C/EBP-b.(95) 
Oppositely, transducin-like enhancer protein 3 (TLE3) 
antagonizes PRDM16 activity thus suppresses brown fat 
differentiation and thermogenesis.(96)
 Beige and brown adipocytes suspected to come 
from distinct cell lineages. However, it was not clear how 
is the cell hierarchy of beige adipocytes. It is found in the 
subcutaneous depot, but do not have a history of Myf5 
expression although beige adipocytes traced by Myf5 
activation was found in retroperitoneal white adipocytes.
(72,90,97) Thus, was it raised from white adipocytes trans-
differentiation, or from precursors maturation de novo? 
Beige adipocytes arose from pre-existing (non-dividing) 
cells which is mature white adipocytes, in response to cold 
or β3-adrenergic agonists (73,74), however other study 
suggested  that  both  cells  have  distinctive  molecular 
profiles (98).
 Notably, only the beige can activate uncoupling 
protein 1 (UCP1) expression in response to  b-adrenergic 
stimulation. Expression of Ebf2 marks a subpopulation of 
adipogenic cells in white AT that are competent for UCP1 
induction, while adipogenic cells with Ebf2-negative will 
turn into UCP1-negative adipocytes.(99) The precursor 
stage between brown/beige and white adipocytes are found 
to have different molecular signatures in adult humans.
(86,94). Beige adipocytes become very appealing, due to its 
highly inducible character, and the recent findings that adult 
BAT largely contains beige-like adipocytes.(11,86,100) 
perhaps by inducing white AT beiging, obese and/or elderly 
people who lack sufficient amounts of active BAT depots 
will be advantaged. Both classical brown adipocytes and 
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in beige adipocytes seemed to be affected by the same 
transcriptional and epigenetic regulators as seen in Figure 
5.(101,102)
 PPAR-γ and the members of the C/EBP protein family 
were known to induce AT  differentiation generally.(103) 
Both were suggested to activate specific thermogenic genes 
in brown and beige adipocytes. For instance, C/EBP-β was 
found at higher amounts in BAT relative to white AT, and 
keep increasing in response to cold.(104) C/EBP-β amount 
increased when β-adrenergic agonists in white AT induce 
the micro RNA (miRNA)-mediated degradation of Hoxc8, 
a repressor of C/EBP-β transcription (105), and triggers 
a brown fat transcriptional profile (104,106). Defect in 
C/EBP-β is associated with defective thermogenesis. 
The activation of β-adrenergic will stimulate the master 
adipogenic factor, PPAR-γ which binds and regulates 
distinct target genes in brown and white fat cells.(107-109)
 Some new myokines recently identified, including 
Irisin and Meteorin-like (METRNL). These myokines 
are induced in muscle through the PGC-1a pathway, and 
administration of both in mice could powerfully activates 
beige adipocyte development.(110,111) In adult humans, 
cold exposure increases circulating irisin.(112) Irisin 
propose the beige adipocyte-gene program in a cell-
autonomous manner, suggested through a selective receptor. 
Human irisin known to employ a noncanonical initiator 
codon (ATA) for its translation, might be subject to complex 
regulation in muscle and/or other tissues.(113) METRNL 
on the other hand, elicit beige adipocyte biogenesis by 
Figure 5. Secreted factors that recruit brown 
adipocytes, beige adipocytes or both. BMP: 
bone morphogenetic protein; FGF: fibroblast 
growth factor; VEGF: vascular endothelial 
growth factor.(102) Adopted with permission 
from Springer Nature).
promoting an eosinophil-dependent activation of M2 anti-
inflammatory macrophages.(111) Exercise could induce 
some myokine such as IL-6, lactate and b-aminoisobutyric 
acid (BAIBA), and promote beige adipocyte biogenesis in 
the subcutaneous white AT depots in mice.(114-116)
 Innate immune pathways also take a role in AT function 
control and at once the systemic glucose homeostasis.
(117,118) Group 2 innate lymphoid cells (ILC2) decreasing 
in white AT is correlated to obesity in humans and mice.
(119) IL-33 is important for ILC2s maintenance in white 
AT, and also needed for beige adipocyte development in 
mice.(11,120). So, IL-33 administration will promote beige 
adipocyte biogenesis and increased whole-body energy 
expenditure, via some mechanisms, which are by increasing 
the production of Metenkephalin peptides by ILC2s (11), 
and by stimulating IL-4 secretion by eosinophils, which acts 
to promote the beige differentiation and proliferation from 
adipogenic precursor cells (120).
 Non-shivering thermogenesis is an increase in 
metabolic heat production which is not associated with 
muscle activity, otherwise by lipolysis in brown adipocytes. 
ATGL or Comparative Gene Identification-58 (CGI-58) 
deletion, which control lipolysis in brown adipocyte, 
apparently does not affect cold-stimulated brown fat 
activity.(121,122) Brown fat thermogenesis can be charged 
by circulating nutrients from diet or generated by lipolysis 
in white AT. For example, long chain fatty acids released 
from WAT are converted to acylcarnitines by liver, and in 
circulation taken up to fuel thermogenesis by the activated 
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BAT.(123) Beige and brown adipocytes in maximum 
stimulation, can achieve similar thermogenic components 
like UCP1 (11,124), although in its development, as in 
lineage tracing studies with Myh11Cre and Acta2Cre 
drivers, beige adipocytes share more similar history to 
muscle cells than brown adipocytes.(125,126)
 Another mechanism for beige adipocyte energy 
expenditure happened through futile creatine cycling, by 
coordinated upregulation of creatine metabolism genes 
and creatine kinase activity.(127) Energy expenditures in 
mice were decreased when creatine synthesis in adipocytes 
was reduced, and they become sensitive to high- fat-diet-
induced obesity (128), and this condition can be rescued by 
supplementation with dietary creatine, appearing creatine to 
regulate adaptive thermogenesis in vivo.  Enzyme secreted 
by peptidase M20 domain-containing protein 1 (PM20D1) 
act bidirectional to fatty acids and amino acids. It promotes 
UCP1-independent uncoupling by regulating the production 
of N-acyl amino acids such as N-oleoyl phenylalanine. 
These N-lipidated amino acids uncouple mitochondrial 
respiration directly thus increase energy expenditure in 
obese animals.(129)
 White AT adipokines have been widely known since a 
few decades ago, initiated by the discovery of leptin which 
show activity toward many biological processes including 
energy homeostasis. Batokines are adipokines secreted by 
BAT, perform autocrine (act on the cell that secretes them), 
paracrine (act on nearby cells), and endocrine (influence 
distant cells and organs) actions which were essential for 
tissue remodeling adaptations and adaptive non-shivering 
thermogenesis. Batokines’ endocrine actions may have a 
role in peptidic and nonpeptidic molecules secreted by both 
brown and beige adipocytes performed autocrine signaling 
properties (130), for example the lipid 12,13-dihydroxy-9Z-
octadecenoic acid (12,13-diHOME), produced in BAT after 
cold exposure activate its biosynthesis enzymes which acts 
to stimulate BAT activity by promoting FA uptake into brown 
adipocytes.(131) Endogenously activated biosynthesis of 
prostaglandin E2 (PGE2) induce white AT browning in mice 
and white fat trans-differentiation into beige adipocytes in 
human.(132,133) Prostaglandin synthesis enzyme lipocalin 
prostaglandin D synthase (L-PGDS) in insufficient levels 
may affect to BAT impairment.(134) Adenosine is released 
when brown adipocytes activates sympathetically, and in 
an autocrine manner, adenosine enhances thermogenic 
activation.(135) On the contrary, brown adipocytes induce 
endocannabinoid release thermogenically which acts as 
an autocrine negative feedback mechanism to control b3-
adrenergic stimulation during BAT activation and browning 
of white AT.(136) C-terminal fragment of SLIT2 (SLIT2-C) 
and PM20D1 are two autocrine factors with positive effects 
on BAT activity. SLIT2-C secreted from beige-adipocyte, 
cleaved from its full-length SLIT2 protein. It induces protein 
kinase A signaling downstream of the b-adrenergic pathway 
to promotes AT thermogenesis.(137) PM20D1 is a secreted 
enzyme. It converts fatty acids and amino acids into N-acyl 
amino acids, which acts as endogenous, UCP1-independent, 
mitochondrial uncouplers and increase cellular respiration.
(138) Paracrine action of BAT is shown in Figure 6A. 
 Several batokines targeting precursor cells 
(commitment) and/or preadipocytes (proliferation and/
or differentiation) to regulate brown and/or beige tissue 
adipogenesis.(139) Some batokines with positive effects 
including PGE2, follistatin, FGF-2, which is also secreted 
by brown adipocytes to induce more proliferation of 
preadipocytes in BAT (140,141), and insulin-like growth 
factor (IGF)-1 induces proliferation and also differentiation 
(142). Some others suppress brown and/or beige 
adipogenesis such as growth differentiation factor 8 (GDF8) 
and endothelin-1. While Nitric oxide (NO), endogenously 
produced in brown adipocytes via adrenergic induction of 
NO synthase activities, inhibits proliferation but inducing 
the differentiation of preadipocytes in primary cultures.
(140) Some factors found to be secreted by preadipocytes 
but not by mature adipocytes such as BMPs, cytokines, and 
plasminogen activator inhibitor 1 also contribute to brown 
adipogenesis.(141,143,144) Endocrine actions of BAT are 
shown in Figure 6B.
 Several batokines including METRNL and FGF-
21 released almost exclusively by beige AT (11,111), was 
related to white AT ‘browning’, which also associated with 
healthy metabolic parameters in human. Thus, activating 
BAT thermogenesis with its batokines regard as a potential 
tools for metabolic therapies. Reviewing the characteristics 
of those AT (summarized in Table 1), a new hope was raised 
to utilized WAT browning to improve insulin sensitivity 
involving batokines and non-shivering thermogenesis as 
a strategy to fight against obesity and its comorbidities. 
However, more studies were need to highlight the best 
agents performed this action.
Genetics and Epigenetics of Adipocyte Metabolism
Obesity and T2DM known as the multifactorial diseases 
involving genetics and non-genetic (including epi-genetic) 
alteration in their etiology. The high rate of IR evidences 
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A.
B.
Figure 6. Paracrine and endocrine action of 
BAT and beige adipocyte.(130) A: Paracrin-
related actions; B: Endocrine-related 
actions.(Adopted with permission from Cell 
Press). NO: nitric oxide; VEGFA: vascular 
endothelial growth factor A; ANGPTL8: 
Angiopoietin Like 8; IL: interleukin; NGF: 
nerve growth factor; NRG4: Neuregulin 4; 
IGF: insulin-like growth factor; FGF: fibroblast 
growth factor; GDF: growth differentiation 
factor; PGE2: prostaglandin E2; BMP8b: 
bone morphogenetic protein 8B; SLIT2: Slit 
homolog 2 protein; IGFBP2:IGF binding 
protein.(130) (Adopted with permission from 
Cell Press).
poses a great burden, especially when we implicate 
its comorbidity with obesity, T2DM, CVDs, and other 
metabolic diseases. As we discuss in the previous sections, 
adipocytes suggested to have an important role contribute to 
IR. Genome-wide association studies (GWAS) has mapped 
the genomes underlying obesity, T2DM, and IR, thus we 
could learn the genes implicated mechanisms in these 
diseases.
 Some genes involving in energy balance regulation, 
variation  in  body  mass  index  (BMI)  have  been  studied 
since the pre-GWAS era from 1970 to 2005 and found 
26 genes,  many  were  implied  in  adipocyte  biology.
(145) As they were polygenic, metabolic diseases need a 
comprehensive gene-based identification. GWAS performed 
a large-scale sequencing to find any common variants 
represent the immense majority of genetic contribution to 
T2DM.(146) They found only a few rare variants affect 
metabolic disease, asserted GWAS to emphasize in the 
identification of common single-nucleotide polymorphisms 
(SNPs).(147)
 Utilizing small cohort studies, GWAS found one locus 
that were strongly associated with metabolic disease, which 
is growth factor receptor bound protein 10 (GRB10), encodes 
an adaptor protein that regulates insulin receptor signaling.
(148) Combination data from an European cohort, the 
Diabetes Genetics Initiative and the Genetic Investigation 
of Anthropometric Traits (GIANT) Consortium identified 
seven new loci trait to obesity.(149) The follow-up study 
demonstrated these loci increased AT mass, and thus total 
body weight but not lean tissue.(150) Five of these loci 
associated with food intake, explain a possible mechanisms 
for its correlation to obesity development.(151) Together 
with new T2DM loci, a strongly enriched effect of 
adipocytokine signaling was found.(152)
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Characteristics White Adipose Tissue Brown Adipose Tissue Beige Adipose Tissue
Developing time After birth, and throughout life Fetal life After birth, and throughout life
Lineage Multiple lineage Myogenic lineage Multiple lineage
Biogenesis Myf5- precursor cells Dermomyotomal precursors that 
express En1, Myf5+, and Pax7
Myf5- cells, induced in respond to 
some environmental condition & 
external cues (chronic cold 
acclimation, exercises, long-term 
treatment of PPAR-g agonist or b3-
adrenergic receptor agonists, etc)
Location Highly heterogenous Dedicated depots (infants), 
relatively homogeneous
Sporadically reside within WAT 
depots
Locus Unilocular Lipids Multilocular Lipids Multilocular Lipids
Mitochondria Low Abundant Present (upon stimulation)
Energy homeostasis Energy Storage Energy expenditure via non-
shivering thermogenesis




N/A UCP1-dependent creatine cycling UCP1-independent (Ca2+ cycling, 
creatine cycling)
Maintenance Transient into Beige Constitutive Transient into White
Secretion Pro- and anti-inflammatory 
adipocytokines; mostly induce 
insulin resistance
Batokines; induce insulin sensitivity 
and improve metabolism
Batokines; induce insulin sensitivity 
and improve metabolism
Table 1. Characteristics of white, brown and beige adipose tissue.
 DNA methylation plays important roles in many 
developmental processes including adipogenesis. Therefore, 
evidences demonstrated its involvement in metabolic 
perturbation, either in the abnormal development of AT or 
adult adipocytes dysfunction.(153-155) For instances, DNA 
methyltransferase (DNMT)1 is crucial for maintaining 
DNA methylation and repressive histone H3K9 methylation 
patterns prior to differentiation, and DNMT inhibition in 
multipotent C3H10T1/2 cells and 3T3-L1 preadipocytes 
induces spontaneous differentiation in response to adipogenic 
inducers, suggesting it represses 3T3-L1 adipogenesis.
(156-158) However, the genetic studies on DNMTs showed 
conflicting results. However, knocking down DNMT1 and 
-3a result in 3T3-L1 adipogenesis impairment.(159) In case 
of PPAR-g and C/EBP, both genes promoters are gradually 
demethylated during 3T3-L1 adipogenesis, according to the 
genes expression increased.(160,161) This accompany with 
the loss of repressive histone marks (H3K9me3) and the 
gain of active marks (e.g., H3K27ac and H3K4me3) (162), 
but the timing regulation is not fully understood.
 Altered adipokines regulation found in obesity and 
obesity-related metabolic issues was some affected by 
regulated by DNA methylation.(162) Leptin is the key 
adipokine to maintain energy homeostasis by mediating 
tissue and brain communication. High leptin level typically 
associated with obesity, suggest as a result of leptin resistance.
(163,164) Recent studies tried to modify the epigenome via 
the manipulation of specific chromatin-modifying enzymes 
and resulted in important metabolic consequences such 
as causing or improving obesity and hyperglycemia.(165) 
Therefore, epigenetic mechanisms were  involved  in  the 
risk of  inherited diabetes and obesity.(166)
 Back to brown and beige thermogenesis feature either 
via UCP1-dependent or UCP1-independent mechanisms 
(involving creatine substrate cycle and calcium futile 
cycle), brown and beige fat perform their effects on 
metabolic physiology by secreting endocrine factors and 
miRNA-containing exosomes that act as the communication 
vesicles to other tissues in the body.(130,167,168) Brown 
fat secretes Neuregulin 4 (NRG-4) that attenuates hepatic 
lipogenesis and liver injury (169,170), and releases 
microRNAs encapsulated in exosomes as important 
messengers for intertissue cross-talk (171,172). A network 
of transcription factors and cofactors govern brown and 
beige fat development and maintenance including PRDM16 
(71,94,173), early B-cell factor-2 (EBF2) (174), PGC-1α 
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(175), Zbtb7B (176), interferon regulatory factor 4 (IRF4) 
(177), Zfp516 (92), and EHMT1 (178), and they were 
interfaced with several long non-coding RNAs (lncRNAs) 
to regulate the adipocyte biology thermogenesis.Metabolomics of Adipose Tissue
Since several decades ago, many interest has focus on 
metabolites produced by AT, especially to monitor obesity-
related metabolic disorders and to find novel diagnostic 
and prognostic biomarkers.(179) Metabolomic is a study 
to compare metabolic profiles of circulating metabolites 
between individuals, in this case refer to obese vs. lean. We 
knew so little about WAT metabolism due to methodological 
difficulties. A pioneer study investigated monozygotic 
(MZ) twins discordant for obesity with a 10- to 25-kg 
weight difference. The acquired obesity was characterized 
by higher circulating proatherogenic and proinflammatory 
lysophosphatidylcholine species concentrations while 
antioxidative ether phospholipids were reduced.(180) 
Another study combined proteomics and metabolomics 
approaches and found several molecules differ the healthy 
lean individuals with obese.(181) They determined 163 
metabolites in serum and found 12 metabolites metabolites 
significantly related to obesity. Glycine, glutamine, and 
glycerophosphatidylcholine 42:0 (PCaa 42:0) were higher, 
whereas PCaa 32:0, PCaa 32:1, and PCaa 40:5 were 
decreased in individuals with obesity compared with lean 
individuals.(181)
 Branched-chain amino acid (BCAA) are a group 
of three essential amino acids: leucine, isoleucine and 
valine, functioning both as direct and/or indirect signals in 
downstream metabolic pathways. Interestingly, while BCAA 
optimal level was needed to improve metabolic health, 
increased BCAA plasma levels are generally associated 
to IR of T2DM. the mechanism could be explained by 
mammalian target of rapamycin complex 1 (mTORC1) 
activation by BCAAs.(182) A research demonstrated that 
constitutive mTORC1 activation can protects the mice from 
high fat diet-induced obesity, and AT inflammation.(183)
 Several studies associated obesity with circulating 
metabolites of the TCA cycle. An investigation of BMI 
in the Framingham Heart Study associate with 69 of 217 
studied metabolites and their pathways i.e., the citric acid 
cycle (e.g., isocitrate, α-ketoglutarate, aconitate), the 
tryptophan pathway (e.g., kynurenine, kynurenic acid), 
and the urea cycle.(184) Obese subjects were differentiated 
into groups of MHO  and metabolically unhealthy obese 
(MUHO) based on their whole-body IR, hepatic steatosis, 
and low-grade inflammation, generally correlated with 
cardiometabolic morbidity or mortality in metabolic 
unhealthy obese (MUHO) subjects compare to MHO.
(185) Another metabolomic study with a total subjects of 
10 insulin-resistant and 10 insulin-sensitive nondiabetic 
Caucasians with morbid obesity (BMI >40 kg/m2), 
matched for gender, age, BMI, and percentage of body fat.
(186) Primary preadipocytes isolated and differentiated 
into adipocytes, and ~280 metabolites were examined 
intracellularly, extracellularly, and in plasma. It was found 
that aspartate was reduced intracellularly to one-third in 
insulin-resistant adipocytes, describe a relative depletion of 
citric acid cycle metabolites and/or reduced aspartate uptake 
in MUHO.(186)
 One main function of white AT is the conversion of 
glucose into FA and vice versa, in order to regulate the energy 
demand and supply.(187) While performing its function 
completing the Cori cycle, white AT  is highly oxygen 
dependent, reduced the O2 concentration on cultured human 
adipocytes in a level above hypoxia, led to major changes in 
adipocyte function, suggested that adipocytes are sensitive 
to small changes in O
2
 tension.(188) Obviously, metabolites 
of the glycolysis pathway have been associated with obesity 
in humans as well.(179)
 An improved human AT metabolome mapping 
provides new insights and potential diagnostic, prognostic, 
and therapeutic tools for a variety of adipose-related 
disorders. Given that obesity has reached a pandemic scale 
and become quite a burden for public health worldwide, 
obesity-related alterations of AT metabolism biomarkers is 
of the utmost importance.(179)
Conclusion
In past few years, adipocytes classification, development, 
and differentiation has been significant changes. Some novel 
perspectives were provided on how adipocytes involved 
in a variety of homeostatic processes and communicate 
with other tissues, as well as how metabolic diseases rose 
from the alteration of these relationships and how we can 
manipulate the mechanisms.
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